One liver, three recipients: segment IV from split-liver procedures as a source of hepatocytes for cell transplantation

Transplantation. 2004 May 27;77(10):1614-6. doi: 10.1097/


Hepatocyte transplantation is emerging as a possible treatment for patients with acute liver failure and liver-based metabolic disorders. With the limited availability of donor tissue, it is important to find new sources of liver tissue for isolation of high-quality hepatocytes. Segment IV with or without the caudate lobe was removed during three split-liver procedures. Hepatocytes were isolated from the tissues using a collagenase perfusion technique under strict sterile conditions. The mean number of hepatocytes that were isolated was 5.14 x 10(8) cells with a mean cell viability of 89%. Two of the hepatocyte preparations were used for cell transplantation in a 1-day-old boy with an antenatal diagnosis of a severe urea cycle defect caused by ornithine transcarbamylase deficiency. The six recipients of split-liver grafts demonstrated no complications related to the removal of segment IV. Segment IV with or without the caudate lobe obtained from split-liver procedures is potentially a good source of high-quality hepatocytes for cell transplantation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Hepatocytes / transplantation*
  • Humans
  • Infant, Newborn
  • Liver Diseases / surgery
  • Male
  • Metabolism, Inborn Errors / surgery
  • Ornithine Decarboxylase / deficiency
  • Tissue and Organ Procurement / methods*
  • Treatment Outcome


  • Ornithine Decarboxylase